J P Morgan Global Alternatives, the Biotechnology Scam, and Tony Blair
Let me know what you think in the comments...
Another cracking article from Fierce Pharma
J.P. Morgan's private financing arm closes inaugural $500M-plus biotech fund
By Gabrielle Masson, Jun 14, 2024 10:37am
“As the biotechnology industry enters the next era of scientific discovery, we strive to become a partner of choice for world-class researchers and entrepreneurs," Gaurav Gupta, M.D., managing partner of J.P. Morgan Life Sciences Private Capital, said.
The 270 fund closed above its $500 million target, though the exact figure was not disclosed.
J.P. Morgan Private Capital has a focus on growth investing and offers customized financing solutions for private companies. The team is a part of J.P. Morgan Asset Management’s alternative investment arm, known as J.P. Morgan Global Alternatives.
Global Alternatives, 03/19/2021
“We discuss our global alternatives platform across private equity, private debt, real assets and hedge funds and review our commitment to diversity.” In the corporate video, we hear from: